环磷酰胺治疗后发生的膀胱尿路上皮癌
[Urothelial carcinoma of the bladder following cyclophosphamide therapy].
作者信息
Blume B, Rabe F, Theuring F
出版信息
Z Urol Nephrol. 1984 Jan;77(1):7-9.
PMID:6702330
Abstract
A report is given on a 73-year-old patient in whom a urothelial carcinoma of the urinary bladder developed 11 years after a cyclophosphamide therapy. Taking the international literature into account, possible developmental mechanisms are discussed. Patients who have undergone cyclophosphamide therapy should be subject to constant urological observation as a high-risk group.
摘要
报告了一名73岁患者，其在环磷酰胺治疗11年后发生了膀胱尿路上皮癌。考虑到国际文献，讨论了可能的发病机制。接受过环磷酰胺治疗的患者作为高危人群应接受持续的泌尿外科观察。
相似文献
1
[Urothelial carcinoma of the bladder following cyclophosphamide therapy].环磷酰胺治疗后发生的膀胱尿路上皮癌
Z Urol Nephrol. 1984 Jan;77(1):7-9.
2
[Carcinoma of the urinary bladder in a patient receiving cyclophosphamide for Wegener's granuloma: a case report].
Hinyokika Kiyo. 1991 Apr;37(4):393-6.
3
[Tumors of the upper urothelium and cyclophosphamide: presentation of a case and review of the literature].
Arch Esp Urol. 1991 Dec;44(10):1149-51.
4
[Urothelial carcinoma after treatment with cyclophosphamide. Review of the literature and presentation of our caseload].
Actas Urol Esp. 1993 Feb;17(2):139-42.
5
Cyclophosphamide associated bladder cancer--a highly aggressive disease: analysis of 12 cases.
J Urol. 1996 Dec;156(6):1931-3.
6
7
Cyclophosphamide-induced transitional cell carcinoma of bladder in lupus nephritis.环磷酰胺诱发狼疮性肾炎患者的膀胱移行细胞癌
Intern Med J. 2002 Mar;32(3):114-6.
8
[Urothelial cancers from Endoxan].
J Urol (Paris). 1984;90(6):411-2.
9
10
Invasive bladder cancer after cyclophosphamide administration for nephrotic syndrome--a case report.
Hiroshima J Med Sci. 2000 Jun;49(2):121-3.
引用本文的文献
1
Comparative activity of ifosfamide and cyclophosphamide.异环磷酰胺与环磷酰胺的活性比较
Cancer Chemother Pharmacol. 1986;18 Suppl 2:S1-9. doi: 10.1007/BF00647438.
Zotero 插件